Founded in Brisbane, Australia in 2018, Gelomics is a biotechnology company revolutionizing drug development and biomedical research. They are dedicated to accelerating therapeutic breakthroughs by enabling the cultivation of advanced human tissue models in vitro, providing ethical, cost-effective, and highly predictive alternatives to traditional animal testing.
Gelomics' flagship LunaX™ 3D Tissue Culture System utilizes innovative photocrosslinkable extracellular matrices to precisely recreate the natural cellular environment. This allows researchers to effortlessly grow complex 3D tissue models with tunable stiffness, ensuring biologically relevant and highly reproducible results in under 15 minutes. Their technology enhances the value of cell-based research across applications like drug discovery, personalized medicine, and disease modeling.
With Gelomics, you gain access to cutting-edge solutions that promise to elevate your research with greater predictability and ethical practice.
